LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Bladder Cancer|Breast Cancer|Colorectal Cancer|Esophageal Cancer|Gastric Cancer|Lung Cancer|Pancreatic Cancer
Interventions: BIOLOGICAL: LMB-9 immunotoxin
Sponsor: National Cancer Institute (NCI)